DBV Technologies S.A. - American Depositary Shares (DBVT) analyst actions
Rating and price-target actions on DBVT in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the DBVT overview →
1 measured DBVT analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| DBV Technologies to Present New Positive Data from VITESSE Study and Preview Recently Initiated THRIVE Study at the EAACI Congress 2026 | Press release | +0.19% | -0.68% |
Keep exploring
More DBVT: earnings → · SEC filings → · DBVT overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| BG MEDICINE INC (BGMD) | 329 | 0.00% | 39% |
| IQVIA Holdings, Inc. (IQV) | 329 | +0.02% | 51% |
| Novartis AG (NVS) | 326 | +0.03% | 51% |
| Theravance Biopharma, Inc. - Ordinary Shares (TBPH) | 326 | +0.10% | 57% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.